SEC
SlamSEC
SearchBrowseEarnings

CNS Pharmaceuticals, Inc.

Nasdaq:CNSP
Pharmaceutical Preparations·HOUSTON, TX
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(367 total)

TypeDateAccessionPeriodSize
4
Mar 4, 2026
0001683168-26-001491
Mar 2, 2026
5.7 KB
3
Mar 4, 2026
0001683168-26-001490
Mar 2, 2026
8.6 KB
4
Mar 4, 2026
0001683168-26-001489
Mar 2, 2026
5.7 KB
3
Mar 4, 2026
0001683168-26-001488
Mar 2, 2026
8.6 KB
8-K
Mar 2, 2026
0001683168-26-001413FORM 8-K
Feb 26, 2026
338.6 KB
S-8
Feb 27, 2026
0001683168-26-001368FORM S-8
—
182.9 KB
8-K
Feb 17, 2026
0001683168-26-001066FORM 8-K
Feb 10, 2026
352.0 KB
SCHEDULE 13G/A
Feb 13, 2026
0000935836-26-000092
—
17.3 KB
4
Jan 2, 2026
0001683168-26-000016
Jan 1, 2026
5.7 KB
3
Jan 2, 2026
0001683168-26-000014
Jan 1, 2026
7.7 KB
8-K
Dec 17, 2025
0001683168-25-009208CURRENT REPORT
Dec 16, 2025
341.8 KB
8-K
Nov 21, 2025
0001683168-25-008624CURRENT REPORT
Nov 17, 2025
950.5 KB
4
Nov 19, 2025
0001683168-25-008576
Nov 17, 2025
5.9 KB
4
Nov 19, 2025
0001683168-25-008566
Nov 17, 2025
6.0 KB
4
Nov 19, 2025
0001683168-25-008564
Nov 17, 2025
6.0 KB
4
Nov 19, 2025
0001683168-25-008565
Nov 17, 2025
5.9 KB
4
Nov 19, 2025
0001683168-25-008563
Nov 17, 2025
6.0 KB
4
Nov 19, 2025
0001683168-25-008562
Nov 17, 2025
6.0 KB
4
Nov 19, 2025
0001683168-25-008561
Nov 17, 2025
5.9 KB
SCHEDULE 13G/A
Nov 14, 2025
0001172661-25-005174
—
10.3 KB
10-Q
Nov 14, 2025
0001683168-25-008466FORM 10-Q FOR SEP 2025
Sep 30, 2025
2.8 MB
DEFA14A
Nov 12, 2025
0001683168-25-008266FORM DEFA14A
—
472.1 KB
SCHEDULE 13G
Nov 4, 2025
0000935836-25-000648
—
17.2 KB
ARS
Oct 28, 2025
0001683168-25-007794ANNUAL REPORT
Dec 31, 2024
1.0 MB
DEF 14A
Oct 24, 2025
0001683168-25-007760DEF 14A
Nov 17, 2025
873.7 KB
25 filings shown
CEO
Levin Rami
CFO
O'Loughlin Steve